홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
QURE
#2145
uniQure N.V.
15.6
3
-9.76%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-9.76%
월간 변동
-34.90%
6달 변화
-1.01%
년간 변동율
+33.02%
이전 종가
17.3
2
Open
15.6
3
Bid
Ask
Low
15.6
3
High
15.6
3
양
137
마켓
주식
헬스케어
QURE
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
44.99 M
46.46 M
46.98 M
47.84 M
54.08 M
—
Valuation ratios
Enterprise value
1.38 B
407.26 M
798.09 M
90.16 M
796.07 M
4.71 B
Price to earnings ratio
—
2.95
-8.06
-1.07
-3.59
-22.97
Price to sales ratio
—
1.85
9.59
20.85
31.68
304.34
Price to cash flow ratio
—
3.37
7.04
2.26
4.7
31.94
Price to book ratio
—
1.63
2.14
1.59
127.24
149.22
Enterprise value to EBITDA ratio
-8.26
1.64
-4.11
-0.28
54.59
-31.41
Profitability ratios
Return on assets %
0.37
0.41
0.18
0.37
0.43
0.05
Return on equity %
0.51
0.55
0.27
1.49
35.48
2.37
Return on invested capital %
-537.78
796.56
-212.61
-426.75
-377.81
-373.73
Gross margin %
92.27
95.23
98.82
99.59
95.33
352.35
Operating margin %
-334.34
59.28
-134.44
-1 785.46
-679.58
-5 600.29
EBITDA margin %
-445.82
47.52
-182.45
-2 064.32
53.77
-1 009.24
Net margin %
333.27
62.9
119.07
1 947.09
883.35
1 295.26
Liquidity ratios
Quick ratio
—
—
6.19
8.68
—
—
Current ratio
9.47
17.09
6.28
8.85
9.74
38.84
Inventory turnover
—
—
0.18
0.01
—
—
Asset turnover
0.1
0.91
0.14
0.02
0.04
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.1
0.12
0.15
0.12
0.09
0.32
Long term debt to total equity ratio
0.15
0.17
0.22
0.49
-7.6
-18.79
Per share metrics
Operating cash flow per share
—
6.15
-3.1
-3.06
-3.76
-2.94
EBIT per share
—
5.19
-4.33
-7.31
-0.13
-1.09
EBITDA per share
—
5.32
-4.16
-6.86
0.3
-0.93
Total debt per share
—
—
—
—
—
—
Cash per share
—
11.88
7.55
12.96
7.56
34.6
Net current asset value per share
—
13.41
10.2
13.67
8.02
36.53
Tangible book value per share
—
10.79
8.38
2.53
-2.06
-1.69
Working capital per share
—
12.63
8.58
12.13
7.2
32.47
Book value per share
—
12.72
10.19
4.36
-0.14
4.52
uniQure N.V
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
뉴스
uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know (NASDAQ:QURE)
유니큐어, AMT-130 규제 경로 주목 속 실적 발표 예정
uniQure earnings in focus as AMT-130 regulatory path looms
유니큐어 주식, FDA 관계자 발언 후 스티펠 논평
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Applied Materials, Broadcom among market cap stock movers on Thursday
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
유니큐어, FDA 언급에 급락…유전자 치료제 임상 관련
UniQure stock tumbles on FDA comments about gene therapy trial
uniQure, Wolfe Research에서 ’Peerperform’ 등급으로 시작
uniQure stock initiated at Peerperform by Wolfe Research